SickKids Innovation Showcase 2024

SickKids Innovation Showcase 2024

Join us for the fourth annual SickKids Innovation Showcase to celebrate our most advanced health and life sciences ideas!

By Industry Partnerships & Commercialization Office, The Hospital for Sick Children

Date and time

Tue, May 28, 2024 1:00 PM - 5:00 PM EDT

Location

Peter Gilgan Centre for Research and Learning - Auditorium

686 Bay Street Toronto, ON M5G 0A4 Canada

Agenda

1:00 PM - 1:15 PM

Opening Remarks

1:15 PM - 1:30 PM

Introduction to Panelists

1:30 PM - 2:30 PM

Technology Pitch Presentations

2:30 PM - 2:45 PM

Coffee Break

2:50 PM - 3:50 PM

Technology Pitch Presentations

3:50 PM - 4:00 PM

Audience Choice Award Live Vote & Winner Announced


The Audience Choice Award is awarded to the best technology pitch of the day, based on a live vote from the audience. The winner receives a prize fund for R&D.

4:00 PM - 4:10 PM

Closing Remarks

4:15 PM

Networking Cocktail Reception


Enjoy some complimentary food and beverages while networking with guests from the health and life sciences community (Gallery event space, 2nd Floor, in-person only).

About this event

  • 4 hours

The fourth annual SickKids Innovation Showcase is taking place on May 28, 2024.

Join us in person as we celebrate the most advanced health and life sciences ideas at SickKids. See our innovators pitch their health technologies to a panel of investors and industry experts over the course of an afternoon.

Geared toward venture capitalists, early-stage investors, biotechnology and pharmaceutical companies, the Innovation Showcase offers attendees unparalleled access to SickKids' top emerging technologies with a high potential for market disruption and impact.

W hen: Tuesday, May 28, 2024 | 1:00-4:15 p.m. | 4:15 p.m. Networking Reception

Where: Auditorium* of the Peter Gilgan Centre for Research and Learning (686 Bay Street, Toronto, ON), followed by a reception in the Gallery (2nd Floor)

Why: Receive exclusive access to some of the top emerging technologies created by our researchers and innovators in the labs of SickKids

Who: VCs and investors in the health and life sciences sector, pharmaceutical and biotechnology companies, innovation partners and organizations in our healthcare ecosystem

*For those who are unable to attend in person, please ensure you register for a virtual ticket to access our live stream of the event.


PRESENTING TECHNOLOGIES:


NewCode Oncology: Improving the speed and accuracy of cancer treatment using an ML-based RNA platform

Adam Shlien, PhD, FCCMG

Senior Scientist, Genetics & Genome Biology | Associate Professor, Laboratory Medicine and Pathobiology, University of Toronto


Small molecule CFTR potentiator for chronic obstructive pulmonary disease

Christine E. Bear, PhD

Senior Scientist, Molecular Medicine | Co-Director, Cystic Fibrosis Centre | Professor, Department of Physiology, University of Toronto


A new treatment approach for DNA repeat expansion diseases

Christopher Edmund Pearson, PhD

Senior Scientist, Genetics & Genome Biology | Canada Research Chair in Disease-Associated Genome Instability | Professor, Department of Molecular Genetics, University of Toronto


A new method for assessing the efficacy of immunotherapies in patients with type one diabetes

Jayne Danska, PhD

Senior Scientist, Genetics and Genome Biology | The Anne and Max Tanenbaum Chair in Molecular Medicine | Associate Chief, Development and Diversity | Professor, Department of Immunology and Medical Biophysics, University of Toronto


A novel approach to using lipid nanoparticles (LNPs) for gene therapy in neuromuscular disease

Jim Dowling, MD, PhD

Senior Scientist, Genetics & Genome Biology | Mogford Campbell Family Chair of Paediatric Neurosciences | Professor, Departments of Paediatrics and Molecular Genetics, University of Toronto


Digital biomarker to revolutionize heart function assessment

Luc Mertens, MD, PhD

Section Head, Echocardiography | Professor, Department of Paediatrics, University of Toronto


RAMalgo: an AI-powered robot for preclinical pain research

Steven Prescott, PhD

Senior Scientist, Neurosciences & Mental Health | Professor, Department of Physiology, University of Toronto


A dual-action peptide for treatment of glioblastoma by targeting cancer cells and immunoactivation

Xi Huang, PhD

Senior Scientist, Developmental and Stem Cell Biology | Canada Research Chair in Cancer Biophysics

Frequently asked questions

I would like to attend this event but I cannot make it in person, what should I do?

Although we believe in-person events provide more opportunity to interact and connect, we understand this may not be an accessible option for everyone. If you would like to attend the 2024 Innovation Showcase virtually, please register for a "Virtual Ticket".

Who should attend this event?

Investors interested in SickKids research and commercialization, innovators in the local health ecosystem, corporate and industry partners, such as pharmaceutical and biotechnology companies, and researchers or clinicians interested in commercialization opportunities at SickKids.

Organized by

The Industry Partnerships and Commercialization (IP&C) office at The Hospital for Sick Children (SickKids) champions the identification, development and commercialization of cutting-edge health research, technology and innovations developed by our scientists and clinicians. We partner with industry and investors to translate SickKids research into products that have health, social and economic benefits.

Free